Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.
Janes PW, Daly RJ, deFazio A, Sutherland RL. Janes PW, et al. Oncogene. 1994 Dec;9(12):3601-8. Oncogene. 1994. PMID: 7970720
Cloning and characterization of GRB14, a novel member of the GRB7 gene family.
Daly RJ, Sanderson GM, Janes PW, Sutherland RL. Daly RJ, et al. Among authors: janes pw. J Biol Chem. 1996 May 24;271(21):12502-10. doi: 10.1074/jbc.271.21.12502. J Biol Chem. 1996. PMID: 8647858
Heregulin (HRG)-induced mitogenic signaling and cytotoxic activity of a HRG/PE40 ligand toxin in human breast cancer cells.
Fiddes RJ, Janes PW, Sanderson GM, Sivertsen SP, Sutherland RL, Daly RJ. Fiddes RJ, et al. Among authors: janes pw. Cell Growth Differ. 1995 Dec;6(12):1567-77. Cell Growth Differ. 1995. PMID: 9019162
Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7.
Janes PW, Lackmann M, Church WB, Sanderson GM, Sutherland RL, Daly RJ. Janes PW, et al. J Biol Chem. 1997 Mar 28;272(13):8490-7. doi: 10.1074/jbc.272.13.8490. J Biol Chem. 1997. PMID: 9079677
Analysis of Grb7 recruitment by heregulin-activated erbB receptors reveals a novel target selectivity for erbB3.
Fiddes RJ, Campbell DH, Janes PW, Sivertsen SP, Sasaki H, Wallasch C, Daly RJ. Fiddes RJ, et al. Among authors: janes pw. J Biol Chem. 1998 Mar 27;273(13):7717-24. doi: 10.1074/jbc.273.13.7717. J Biol Chem. 1998. PMID: 9516479
Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
Fiddes RJ, Janes PW, Sivertsen SP, Sutherland RL, Musgrove EA, Daly RJ. Fiddes RJ, et al. Among authors: janes pw. Oncogene. 1998 May 28;16(21):2803-13. doi: 10.1038/sj.onc.1201815. Oncogene. 1998. PMID: 9652748
The role of lipid rafts in T cell antigen receptor (TCR) signalling.
Janes PW, Ley SC, Magee AI, Kabouridis PS. Janes PW, et al. Semin Immunol. 2000 Feb;12(1):23-34. doi: 10.1006/smim.2000.0204. Semin Immunol. 2000. PMID: 10723795 Review.
Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines.
deFazio A, Chiew YE, Sini RL, Janes PW, Sutherland RL. deFazio A, et al. Among authors: janes pw. Int J Cancer. 2000 Aug 15;87(4):487-98. Int J Cancer. 2000. PMID: 10918187
Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.
Vail ME, Murone C, Tan A, Hii L, Abebe D, Janes PW, Lee FT, Baer M, Palath V, Bebbington C, Yarranton G, Llerena C, Garic S, Abramson D, Cartwright G, Scott AM, Lackmann M. Vail ME, et al. Among authors: janes pw. Cancer Res. 2014 Aug 15;74(16):4470-81. doi: 10.1158/0008-5472.CAN-14-0218. Cancer Res. 2014. PMID: 25125683
Eph receptor signalling: from catalytic to non-catalytic functions.
Liang LY, Patel O, Janes PW, Murphy JM, Lucet IS. Liang LY, et al. Among authors: janes pw. Oncogene. 2019 Sep;38(39):6567-6584. doi: 10.1038/s41388-019-0931-2. Epub 2019 Aug 12. Oncogene. 2019. PMID: 31406248 Review.
33 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback